CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoHORENSTEIN, ALBERTO
Pubblicazioni
Risultati 1 - 20 di 52 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. | 2013 | Horenstein AL;Chillemi A;Zaccarello G;Bruzzone S;Quarona V;Zito A;Serra S;Malavasi F |
| 2 | Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase | 2007 | CURTI A; ALUIGI M; PANDOLFI S; FERRI E; ISIDORI A; SALVESTRINI V; DURELLI I; HORENSTEIN AL; FIORE F; MASSAIA M; PICCIOLI M; PILERI SA; ZAVATTO E; D'ADDIO A; BACCARANI M; LEMOLI RM |
| 3 | The ADP-ribosyl cyclases - the current evolutionary state of the ARCs | 2014 | Ferrero E; Lo Buono N; Horenstein AL; Funaro A; Malavasi F. |
| 4 | Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. | 2013 | Chillemi A;Zaccarello G;Quarona V;Ferracin M;Ghimenti C;Massaia M;Horenstein AL;Malavasi F |
| 5 | Biosensor analysis of antigen-antibody interactions as a priority step in the generation of monoclonal bispecific antibodies. | 1994 | HORENSTEIN A ;POIESI C ;CAMAGNA M ;DE MONTE L ;MARIANI M ;ALBERTINI A ;MALAVASI F |
| 6 | CD157, the Janus of CD38 but with a unique personality. | 2002 | Ortolan E; Vacca P; Capobianco A; Armando E; Crivellin F; Horenstein A; Malavasi F. |
| 7 | The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes. | 2011 | Lo Buono N; Parrotta R; Morone S; Bovino P; Nacci G; Ortolan E; Horenstein AL; Inzhutova A; Ferrero E; Funaro A |
| 8 | CD38 and bone marrow microenvironment. | 2014 | Chillemi A;Zaccarello G;Quarona V;Lazzaretti M;Martella E;Giuliani N;Ferracini R;Pistoia V;Horenstein AL;Malavasi F |
| 9 | CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival | 2005 | DEAGLIO S; VAISITTI T; BERGUI L; BONELLO L; HORENSTEIN AL; TAMAGNONE L; BOUMSELL L; MALAVASI F |
| 10 | CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity | 2006 | MALAVASI F; DEAGLIO S; FERRERO E; FUNARO A; SANCHO J; AUSIELLO CM; ORTOLAN E; VAISITTI T; ZUBIAUR M; FEDELE G; AYDIN S; TIBALDI EV; DURELLI I; LUSSO R; CORNO F; HORENSTEIN AL |
| 11 | CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus | 2009 | Horenstein AL; Sizzano F; Lusso R; Besso FG; Ferrero E; Deaglio S; Corno F; Malavasi F |
| 12 | CD38 and CD157: A long journey from activation markers to multifunctional molecules. | 2013 | Quarona V;Zaccarello G;Chillemi A;Brunetti E;Singh VK;Ferrero E;Funaro A;Horenstein AL;Malavasi F |
| 13 | CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia | 2005 | BOLOGNESI A; POLITO L; FARINI V; BORTOLOTTI M; TAZZARI PL; RATTA M; RAVAIOLI A; HORENSTEIN AL; STIRPE F; BATTELLI MG; MALAVASI F |
| 14 | CD38 binding to human myeloid cells is mediated by mouse and human CD31. | 1998 | HORENSTEIN AL ;STOCKINGER H ;IMHOF BA ;MALAVASI F |
| 15 | CD38 e autismo. Genetica e ricadute nella pratica clinica | 2013 | Brunetti Enrico; Zaccarello Gianluca; Chillemi Antonella; Fusco Roberta; Quarona Valeria; Cometa Luisa; Gandione M; Balzola F; Omedè Paola; Geuna Massimo; Rigardetto R; Horenstein AL; Malavasi Fabio |
| 16 | CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells | 2010 | Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S |
| 17 | CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation | 2013 | Fedele G;Di Girolamo M;Recine U;Palazzo R;Urbani F;Horenstein AL;Malavasi F;Ausiello CM |
| 18 | CD38 Workshop Report | 1997 | M. Morra; S. Deaglio; R. Mallone; G. Di Rosa; E. Tibaldi; G. Zini; C. Cinti; F. Saccucci; M. Reinis; A.L. Horenstein; E. Ferrero; A. Funaro; T. Katada; F. Malavasi |
| 19 | CD56<sup>bright</sup>CD16<sup>-</sup> NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4<sup>+</sup> T cell proliferation | 2015 | Morandi, Fabio; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Chiesa, Sabrina; Imperatori, Andrea; Zanellato, Silvia; Mortara, Lorenzo; Gattorno, Marco; Pistoia, Vito; Malavasi, Fabio |
| 20 | CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells | 2011 | Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio |
Dettaglio
HORENSTEIN, ALBERTO
SCIENZE MEDICHE
Copyright © 2020